CSIMarket
 
Telix Pharmaceuticals Ltd  (NASDAQ: TLX)
 

Telix Pharmaceuticals Ltd's Suppliers Performance

TLX's Supply Chain




 
TLX Costs vs Sales of Suppliers Growth

More on TLX Suppliers






Telix Pharmaceuticals Ltd's Comment on Supply Chain


The company sources a variety of raw materials, including biologics and specialized inputs obtained from third parties globally. These materials consist of biologically derived substances as well as those produced from fossil fuel-based feedstocks or complex chemical processes. Environmental and regulatory factors can affect the availability and cost of these materials, potentially resulting in increased procurement expenses, the need for reformulation, or manufacturing delays. The company is also working to transition to a lower-carbon supply chain, which may involve significant investments and operational adjustments. Additionally, the company produces hazardous, radioactive, and biologically active waste that must be managed in accordance with evolving environmental, health, and safety regulations, potentially leading to higher costs and requiring investment in infrastructure or third-party services.

Telix Pharmaceuticals Ltd's Comment on Supply Chain


The company sources a variety of raw materials, including biologics and specialized inputs obtained from third parties globally. These materials consist of biologically derived substances as well as those produced from fossil fuel-based feedstocks or complex chemical processes. Environmental and regulatory factors can affect the availability and cost of these materials, potentially resulting in increased procurement expenses, the need for reformulation, or manufacturing delays. The company is also working to transition to a lower-carbon supply chain, which may involve significant investments and operational adjustments. Additionally, the company produces hazardous, radioactive, and biologically active waste that must be managed in accordance with evolving environmental, health, and safety regulations, potentially leading to higher costs and requiring investment in infrastructure or third-party services.







TLX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Telix Pharmaceuticals Ltd 3,965.02 782.68 49.92 1,120
SUBTOTAL 0.00 0.00 0.00 -


Sources: Telix Pharmaceuticals Ltd's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Telix Pharmaceuticals Ltd’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.